Align Technology, Inc.

NasdaqGS:ALGN Voorraadrapport

Marktkapitalisatie: US$10.7b

Align Technology Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van Align Technology is gedaald met een gemiddeld jaarlijks percentage van -12.4%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 18.2%. De inkomsten zijn groeide met een gemiddeld percentage van 1.7% per jaar. Het rendement op het eigen vermogen Align Technology bedraagt 9.8% en de nettomarge bedraagt 10%.

Belangrijke informatie

-12.35%

Groei van de winst

-10.17%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie8.90%
Inkomstengroei1.71%
Rendement op eigen vermogen9.77%
Nettomarge9.99%
Volgende winstupdate28 Oct 2026

Recente prestatie-updates uit het verleden

Analyse-artikel • May 18

We Like Align Technology's (NASDAQ:ALGN) Earnings For More Than Just Statutory Profit

Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...

Recent updates

Seeking Alpha • Aug 07

Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple

Summary Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow. Key risks include EU antitrust investigation, North American demand softness, iTero revenue declines, and potential activist-driven structural changes. Read the full article on Seeking Alpha
Narratiefupdate • Jul 30

ALGN: Future Returns Will Depend On Execution And EU Antitrust Resolution

Align Technology's updated analyst model trims the fair value estimate by $5 to $170 as analysts factor in a slightly lower assumed revenue growth profile, a modestly higher margin outlook, and a reduced future P/E multiple, despite recent price target support from firms citing potential long term drivers and limited fundamental impact from the EU antitrust case. Analyst Commentary on Align Technology Street research on Align Technology presents a mixed picture, with some analysts highlighting long term growth drivers while others focus on valuation risks and legal overhangs.
Narratiefupdate • Jul 01

ALGN: Platform Execution And Limited EU Antitrust Impact Will Drive Repricing

Align Technology's updated analyst price target moves higher to $209.07, with analysts pointing to detailed platform growth levers and limited expected fundamental impact from the EU antitrust case as key supports for the revised fair value and P/E assumptions. Analyst Commentary Analysts covering Align Technology describe a mix of supportive long-term growth drivers and near term headline risks, with recent price targets and commentary reflecting how they weigh platform execution against regulatory uncertainty.
Narratiefupdate • Jun 17

ALGN: Multi-Year Upside Will Rely On Platform Expansion And Direct Fabrication

Align Technology's latest narrative update keeps the fair value unchanged at $240.00. Analysts point to a slightly lower discount rate, modestly adjusted revenue growth and profit margin assumptions, and Street research highlighting teen conversion, restorative treatment partnerships, software improvements, and direct fabrication scaling as reasons for a higher collective price target outlook.
Narratiefupdate • Jun 02

ALGN: Future Returns Will Rely On Execution And Elliott Engagement

Analysts have nudged their price expectations for Align Technology higher, setting a new target of $175.00. This view is supported by the belief that multiple growth levers across teen conversion, restorative treatments, peer-to-peer expansion, software evolution, and manufacturing scale may not yet be fully reflected in the current stock price.
Analyse-artikel • May 18

We Like Align Technology's (NASDAQ:ALGN) Earnings For More Than Just Statutory Profit

Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...
Narratiefupdate • May 12

ALGN: Higher Future Multiple Will Depend On Execution And Elliott Engagement

Narrative Update on Align Technology The updated analyst price target for Align Technology moves to $175.00 from $152.60, with analysts citing a higher assumed future P/E multiple, along with slightly lower modeled revenue growth and profit margins, as key reasons for the change. Analyst Commentary Recent research on Align Technology reflects a mix of optimism and caution, with several firms adjusting price targets and ratings over the past few months.
Narratiefupdate • Apr 21

ALGN: Higher Fair Value Will Follow Renewed Bullish Rating And Governance Catalyst

The analyst fair value estimate for Align Technology moves to $240 from $225, with analysts pointing to recent Street research that reflects updated views on revenue growth, margins, and P/E assumptions following multiple price target raises and positive rating actions. Analyst Commentary Recent Street research on Align Technology has leaned more constructive, with several bullish analysts updating their views on the company and its valuation framework.
Narratiefupdate • Apr 07

ALGN: Post Conflict Recovery And Elliott Involvement Will Drive Bullish Repricing

The analyst price target for Align Technology holds at $200, as analysts point to an improved risk/reward skew after the recent pullback and highlight the company as well positioned once regional conflict pressures ease. Analyst Commentary Bullish analysts see the recent pullback as improving the setup for Align Technology, with the stock trading below its February levels after a 15% decline linked to Middle East conflict headlines.
Narratiefupdate • Mar 23

ALGN: Post Conflict Demand Recovery And Elliott Engagement Will Shape Bullish Risk Reward

Align Technology's analyst fair value estimate has shifted modestly higher to about $201.69 from $198.67, as analysts point to an improved risk and reward setup following recent share weakness and a series of price target increases. These include a reiterated $200 target alongside an upgrade to Overweight at Barclays, as well as similar upward moves from several other firms.
Narratiefupdate • Mar 08

ALGN: Higher Fair Value Will Reflect Stronger Revenue And Margin Assumptions

The analyst fair value estimate for Align Technology has moved to $225 from $220, with the shift supported by recent price target increases across multiple firms and updated assumptions for revenue growth, profit margin, and a lower future P/E, partially offset by a higher discount rate. Analyst Commentary Recent Street research has centered on higher price targets and at least one fresh upgrade, which together align with the updated fair value estimate of US$225.
Narratiefupdate • Feb 22

ALGN: Margin Execution And P/E Expectations Will Shape Fairly Balanced Outlook

Align Technology's analyst price target has moved higher, with fair value estimates shifting from about $184 to roughly $199. Analysts are factoring in slightly stronger margin assumptions and a higher future P/E multiple, supported by a series of recent price target increases across major firms.
Narratiefupdate • Feb 08

ALGN: Future Multiple Compression Risk Will Test Execution Dependent Story

Analysts have lifted their price expectations for Align Technology, reflected in a higher implied fair value from about $140.00 to roughly $152.60, citing updated assumptions around revenue growth, profitability and future P/E multiples in recent research. Analyst Commentary Recent research activity around Align Technology has centered on revisiting fair value frameworks, with several firms adjusting price targets based on updated views of revenue potential, profitability and appropriate P/E multiples.
Narratiefupdate • Jan 25

ALGN: Q3 Volume Strength And Visibility Concerns Will Shape Balanced Outlook

Analysts have nudged their fair value estimate for Align Technology up by about $3 to $183.87, citing recent price target increases that reflect improved confidence in the company’s volume trends and revenue visibility following Q3 results. Analyst Commentary Recent research on Align Technology highlights a mix of optimism on execution following Q3 and ongoing caution around demand visibility and expectations for upcoming quarters.
Narratiefupdate • Jan 10

ALGN: Q3 Volume Strength And Cautious Outlook Will Shape Fairly Balanced Expectations

Narrative Update The analyst price target for Align Technology is now framed by a modestly higher intrinsic value estimate of about $180.47 per share, as analysts weigh recent target revisions around $200 and $170 against updated assumptions for growth, margins and future P/E. Analyst Commentary Recent Street commentary on Align Technology reflects a mix of renewed confidence in execution and ongoing caution around revenue visibility and the path to growth.
Analyse-artikel • Jan 04

Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Narratiefupdate • Dec 21

ALGN: Q3 Volume Gains Will Support Renewed Confidence In Upcoming Revenue Ramp

Analysts have modestly raised their price target on Align Technology to $200 from $190, reflecting improved confidence in management's restored revenue visibility and Q4 execution following broad-based Q3 volume upside, even as valuation assumptions and long term growth forecasts remain largely unchanged. Analyst Commentary Recent Street commentary on Align Technology reflects a more constructive stance on near term execution, balanced by lingering questions around the durability of growth and visibility into 2025.
Narratiefupdate • Dec 07

ALGN: Q3 Volume Strength Will Support Confidence In Upcoming Revenue Ramp

Analysts have nudged their average price target on Align Technology modestly higher, by roughly $4 to about $184, as stronger than expected Q3 volume trends and improved visibility into hitting year end revenue goals outweighed lingering concerns about the pace of sequential improvement. Analyst Commentary Recent research updates reflect a generally constructive stance on Align Technology, with some lingering caution around execution into Q4 and beyond.
Narratiefupdate • Nov 23

ALGN: Recent Revenue Upside Will Improve Confidence In Forward Momentum

Analysts have raised their price target for Align Technology from $190 to $200 per share, citing improved revenue visibility and a stronger than expected third-quarter performance. Analyst Commentary Analysts have weighed in with both optimism and caution regarding Align Technology's outlook, highlighted by recent changes in price targets and ratings.
Narratiefupdate • Nov 08

ALGN: Volume Upside and Margin Strength Will Drive a Positive Outlook

Analysts have increased their price target for Align Technology from $175.07 to $180.50, citing improved revenue growth prospects, a stronger profit margin outlook, and management's recent success in delivering volume upside despite concerns about seasonality. Analyst Commentary Recent analyst updates on Align Technology reflect a range of perspectives, highlighting both positive developments and ongoing concerns in the company's outlook.
Narratiefupdate • Oct 24

Digital Workflow Improvements And Market Weakness Will Shape The Coming Year

Analysts have lowered their price target for Align Technology by approximately $5 to $175. They cite slightly softer revenue growth projections, modestly reduced profit margin expectations, and increased uncertainty around guidance for the upcoming quarters.
Narratiefupdate • Oct 10

Emerging Markets And Digital Workflow Will Fuel Future Success

Analysts have modestly lowered their price target for Align Technology, trimming it by approximately $6 to $180. Updated industry surveys and company results reflect both ongoing optimism and continued challenges in the dental market.
Seeking Alpha • Mar 07

Align Technology: Brace Yourself, This Stock Is Undervalued

Summary Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation. ALGN's market potential is strong, particularly with younger demographics, although recent revenue per shipment has softened. Read the full article on Seeking Alpha

Opbrengsten en kosten

Hoe Align Technology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NasdaqGS:ALGN Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 264,1404141,787377
31 Mar 264,0964301,774371
31 Dec 254,0354101,756370
30 Sep 253,9833781,739382
30 Jun 253,9654381,755374
31 Mar 253,9814101,759370
31 Dec 243,9994211,763364
30 Sep 243,9614421,741351
30 Jun 243,9434471,715355
31 Mar 243,9174621,716351
31 Dec 233,8624451,703347
30 Sep 233,8073631,711348
30 Jun 233,7373141,701336
31 Mar 233,7053151,675321
31 Dec 223,7353621,674305
30 Sep 223,8645111,716294
30 Jun 223,9906191,745283
31 Mar 224,0317061,751268
31 Dec 213,9537721,709250
30 Sep 213,7567401,606227
30 Jun 213,4746981,490206
31 Mar 212,8164581,315188
31 Dec 202,4721,7761,201175
30 Sep 202,2871,7381,132168
30 Jun 202,1601,7011,097163
31 Mar 202,4091,8891,108161
31 Dec 192,4074431,072157
30 Sep 192,2914191,019152
30 Jun 192,189417956145
31 Mar 192,079376900137
31 Dec 181,966400852129
30 Sep 181,854313808119
30 Jun 181,734295763111
31 Mar 181,600258714104
31 Dec 171,47323166698
30 Sep 171,34526961493
30 Jun 171,23923857189
31 Mar 171,15121953083
31 Dec 161,08019049176
30 Sep 161,01719146068
30 Jun 1694616743565
31 Mar 1688614841462
31 Dec 1584514439061
30 Sep 1581413537761

Kwaliteitswinsten: ALGN heeft een grote eenmalige verlies van $190.7M wat gevolgen heeft voor de financiële resultaten van de laatste 12 maanden tot 30th June, 2026.

Groeiende winstmarge: De huidige netto winstmarges (10%) ALGN } zijn lager dan vorig jaar (11%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van ALGN is de afgelopen 5 jaar met 12.4% per jaar gedaald.

Versnelling van de groei: De winstgroei ALGN is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.

Winst versus industrie: ALGN had het afgelopen jaar een negatieve winstgroei ( -5.5% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Medical Equipment ( 20.4% ).

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 9.8% ) van ALGN wordt als laag beschouwd.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/14 11:39
Aandelenkoers aan het einde van de dag2026/09/14 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Align Technology, Inc. wordt gevolgd door 43 analisten. 16 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Jeffrey JohnsonBaird
Glen SantangeloBarclays
Charley JonesBarrington Research Associates, Inc.